Calls
1
u/Emre_G010
Reddit r/biotech_stocks
Win Rate
0.0%
return
-5.9%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 05
$8.31
-5.9%
The author is entering ALMS because insiders purchased $20 million of shares in November and December ahead of Phase 3 top-line results expected early Q1 2026. The dispute with Climb Bio over a $3 million milestone sent the share price down, which the author sees as a higher return entry. The primary catalyst is the upcoming Phase 3 data announcement.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Emre_G010 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: ALMS.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
